This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology

Eur Urol. 2007 Jul;52(1):259-60.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / enzymology
  • Erectile Dysfunction / physiopathology
  • Humans
  • Male
  • Muscle Contraction / drug effects*
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / physiopathology
  • Penile Erection / drug effects
  • Penile Erection / physiology*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Prognosis

Substances

  • Phosphodiesterase Inhibitors
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human